SCHEMBL13675194

SCHEMBL13675194

Cc1cc(Nc2ncnc3nc(Nc4ccc(CN5CCSCC5)cc4)sc23)ccc1F

nearest known ligand 0.70

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 19/20 0.70
AXL P30530 1/20 0.44
CDK1 P06493 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13675158 0.93 EGFR (0.81) EGFRAXLCDK1
SCHEMBL13674980 0.92 EGFR (0.82) EGFRAXLCDK1
SCHEMBL13674979 0.91 EGFR (0.70) EGFRAXL
SCHEMBL13675161 0.90 EGFR (0.82) EGFRAXL
SCHEMBL13672619 0.90 EGFR (0.86) EGFRAXL
SCHEMBL14462159 0.88 EGFR (0.68) EGFRCDK1
SCHEMBL13675193 0.87 EGFR (0.65) EGFRAXL
SCHEMBL13674982 0.85 EGFR (0.62) EGFRCDK1
SCHEMBL13675165 0.83 EGFR (0.71) EGFR
SCHEMBL13672611 0.83 EGFR (1.00) EGFRAXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605154-B2 ATP-protein kinase inhibitors; cytomegalovirus; contraceptive agents; cancer; N7-(3-ethynyl-phenyl)-N2-(4-piperidin-1-ylmethyl-phenyl)-thiazolo[4,5-d]pyrimidine-2,7-diamine JANSSEN PHARMACEUTICA N.V. (BE) 2009-10-20 US disclosed